Benzinga
Hims & Hers Health Q3 2026 Earnings Call Transcript - Hims & Hers Health (NYSE:HIMS)
xCruzo Brief
Hims & Hers Health (NYSE: HIMS) reported Q3 2026 revenue of $890 million, up 49% year over year, and said it was the second straight quarter of accelerating growth. The company highlighted international expansion as a key driver, projecting a $1 billion international revenue run rate in 2027, supported by momentum in the UK, Germany, and Australia. In domestic weight loss, management described a marketing pullback to prepare for expanded partnerships with Novo and Lilly. Hims & Hers also plans to use its AI-native platform to improve provider efficiency and customer interactions. Q4 2026 revenue guidance is $875–$895 million, while Q3 included a $33 million net loss, $82 million adjusted EBITDA, and $26 million free cash flow.
xCruzo quick-read summary • Source: Benzinga • Read the full article for complete information.
xCruzo
La OMS, una idea maravillosa que necesita reparación": María P. Neira, candidata a dirigir la OMS
Low Symptom Concordance Linked to Worse Quality of Life in Breast Cancer
Long-Term Peyronie's Surgery Study Compares Nesbit and Yachia Patient
Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Beneficios de beber jugo verde en las mañanas y por qué incluirlo en tu desayuno
Izaskun Basterra, psicóloga, sobre los hijos de padres separados: "Cuando un niño pasa de una casa a otra, no cambia únicamente de espacio físico, sino también de rutinas, horarios o normas"
Porcinos: ¿cómo el sector pasó a liderar la transformación del consumo de carnes en el país?
Phoenix Service Partners prueba una nueva tecnología que reduce drásticamente las emisiones de metano sin conexión a la red eléctrica